This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?

Nature News2026-11-03 20:080 views

Nature, Published online: 03 November 2026; doi:10.1038/d41586-026-03504-2

Physicians were excited about several therapies that slash levels of lipoprotein(a) — an important cardiovascular risk factor. One major trial failed to show a benefit, and now scientists are scrambling to work out what that means.

Source：https://www.nature.com/articles/d41586-026-03504-2

My favorites

PreviousWill AI grant reviews make science more conservative?NextDaily briefing: ‘A triumph of scientific self-correction’

Show HN: A landing page that shows every psychological trick it uses on you

Article URL: https://kickstartsidehustle.com/ Comments URL: https://news.ycombinator.com/item?id=50355470 Points: 2 # Co

0Hacker News Show

Show HN: Who can publish to your NPM dependencies?

Article URL: https://www.whosthere.dev/ Comments URL: https://news.ycombinator.com/item?id=50355555 Points: 1 # Comments

0Hacker News Show

kitty 0.50.0

Comments

0Lobsters

I tried Sonos’ latest app features – these 2 small upgrades fix big annoyances

New Sonos software and firmware updates are rolling out. Here’s what you can expect.

0ZDNet

Optimized fuzzy logic controller cuts average robotic arm tracking error by 89% in simulations

A genetically optimized fuzzy logic controller for robotic arms is described in the International Journal of Automation

0Phys.org Tech

Improving community readiness for evacuations with electric vehicles

When natural disasters like wildfires or flooding strike, thousands of people may be told to pack their belongings into